Kogenate FS and Ramucirumab Intravenous
Determining the interaction of Kogenate FS and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: n.a.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kogenate FS-Ranexa
- Kogenate FS-Ranibizumab
- Kogenate FS-Ranibizumab Intraocular
- Kogenate FS-Ranibizumab ophthalmic
- Kogenate FS-Ranitidine
- Kogenate FS-Ranitidine Capsule
- Ramucirumab Intravenous-Kogenate FS Bio-Set
- Ramucirumab Intravenous-Kogenate FS recombinant
- Ramucirumab Intravenous-Kola-Pectin
- Ramucirumab Intravenous-Kola-Pectin DS
- Ramucirumab Intravenous-Kolephrin
- Ramucirumab Intravenous-Kombiglyze XR